Trademark: 97079346
Word
CENTER FOR BREAKTHROUGH MEDICINES AT DISCOVERY LABS
Status
Dead
Status Code
602
Status Date
Saturday, October 1, 2022
Serial Number
97079346
Mark Type
3000
Filing Date
Monday, October 18, 2021
Abandoned Date
Tuesday, September 20, 2022

Trademark Owner History
CENTER FOR BREAKTHROUGH MEDICINES HOLDINGS, LLC - 1st New Owner Before Publication
MORNING LIGHT IP, LLC - Original Applicant

Classifications
44 Manufacturing services for others in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; manufacturing services for others in the fields of mammalian cell banks, plasmids, adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in humans and animals; manufacturing process consulting
42 Research and development services in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; consulting services in the fields of research and development for gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; research and development of new products for others; process development services in the nature of research and development of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; scientific research and technical research services, namely, production of cell lines for others using lentivirus technology; scientific research and technical research services relating to producing, assaying and purifying recombinant or manipulated lentivirus; Scientific and technical consulting services relating to producing, assaying, and purifying adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in humans and animals; advisory services relating to research and development of gene therapy products and biopharmaceuticals; manufacturing support services for others, namely, cGMP (Current Good Manufacturing Practice) quality control testing in support of biopharmaceutical development and manufacturing; quality control for others; quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; material testing; product quality testing; scientific laboratory services; scientific research
The mark consists of an artistic rendition of a molecular line drawing cut off by two horizonal lines to the right are the words CENTER FOR BREAKTHROUGH MEDICINE AT DISCOVERY LABS.

Trademark Events
Oct 3, 2022
Abandonment Notice E-Mailed - Failure To Respond
Oct 1, 2022
Abandonment - Failure To Respond Or Late Response
Mar 18, 2022
Notification Of Non-Final Action E-Mailed
Mar 18, 2022
Non-Final Action E-Mailed
Mar 18, 2022
Non-Final Action Written
Mar 4, 2022
Assigned To Examiner
Jan 26, 2022
Automatic Update Of Assignment Of Ownership
Nov 5, 2021
Notice Of Design Search Code E-Mailed
Nov 4, 2021
New Application Office Supplied Data Entered In Tram
Oct 21, 2021
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24